Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Preferred Shares (2016 - 2025)

Historic Preferred Shares for Sunshine Biopharma (SBFM) over the last 12 years, with Q3 2025 value amounting to $13000.0.

  • Sunshine Biopharma's Preferred Shares changed 0.0% to $13000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $13000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $13000.0 for FY2024, which is 120000.0% up from last year.
  • According to the latest figures from Q3 2025, Sunshine Biopharma's Preferred Shares is $13000.0, which was down 0.0% from $13000.0 recorded in Q2 2025.
  • Over the past 5 years, Sunshine Biopharma's Preferred Shares peaked at $100000.0 during Q1 2021, and registered a low of $1000.0 during Q1 2022.
  • For the 5-year period, Sunshine Biopharma's Preferred Shares averaged around $26263.2, with its median value being $13000.0 (2024).
  • Its Preferred Shares has fluctuated over the past 5 years, first tumbled by 9900.0% in 2022, then soared by 120000.0% in 2024.
  • Over the past 5 years, Sunshine Biopharma's Preferred Shares (Quarter) stood at $100000.0 in 2021, then crashed by 99.0% to $1000.0 in 2022, then changed by 0.0% to $1000.0 in 2023, then soared by 1200.0% to $13000.0 in 2024, then changed by 0.0% to $13000.0 in 2025.
  • Its Preferred Shares was $13000.0 in Q3 2025, compared to $13000.0 in Q2 2025 and $13000.0 in Q1 2025.